{rfName}
In

Indexed in

License and Use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Duarte, RfAuthor

Share

June 6, 2022
Publications
>
Article

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Publicated to: BONE MARROW TRANSPLANTATION. 57 (8): 1217-1239 - 2022-08-01 57(8), DOI: 10.1038/s41409-022-01691-w

Authors:

Snowden, JA; Sánchez-Ortega, I; Corbacioglu, S; Basak, GW; Chabannon, C; de la Camara, R; Dolstra, H; Duarte, RF; Glass, B; Greco, R; Lankester, AC; Mohty, M; Neven, B; de Latour, RP; Pedrazzoli, P; Peric, Z; Yakoub-Agha, I; Sureda, A; Kröger, N
[+]

Affiliations

Ctr Invest Clin Biotherapies Inserm CBT 1409, Marseille, France - Author
EBMT Execut Off, Barcelona, Spain - Author
Fdn IRCCS Policlin San Matteo, Pavia, Italy - Author
HELIOS Klinikum Berlin Buch, Klin Hamatol & Stammzelltransplantat, Berlin, Germany - Author
Hosp Duran & Reynals, Inst Catala Oncol, Barcelona, Spain - Author
Hosp Princesa, Hematol, Madrid, Spain - Author
Inst Paoli Calmettes Comprehens Canc Ctr, Marseille, France - Author
IRCCS San Raffaele Sci Inst, Haematol & Bone Marrow Transplant Unit, Milan, Italy - Author
Leiden Univ, Willem Alexander Childrens Hosp, Med Ctr, Leiden, Netherlands - Author
Med Univ Warsaw, Univ Clin Ctr, Dept Hematol Transplantat & Internal Med, Warsaw, Poland - Author
Paris Diderot Univ, St Louis Hosp, Paris, France - Author
Radboud Univ Nijmegen, Dept Lab Med, Lab Hematol, Med Ctr, Nijmegen, Netherlands - Author
Sheffield Teaching Hosp NHS Fdn Trust, Dept Haematol, Sheffield, S Yorkshire, England - Author
Sorbonne Univ, St Antoine Hosp, AP HP, INSERM UMRs 938, Paris, France - Author
Univ Autonoma Madrid, Hosp Univ Puerta de Hierro Majadahonda, Madrid, Spain - Author
Univ Lille, Infinite, INSERM U1286, CHU Lille, F-59000 Lille, France - Author
Univ Med Ctr Hamburg, Hamburg, Germany - Author
Univ Paris Cite, Necker Children Hosp, AP HP, Pediat Immunohematol Unit, Paris, France - Author
Univ Pavia, Pavia, Italy - Author
Univ Regensburg, Regensburg, Germany - Author
Univ Zagreb, Sch Med, Zagreb, Croatia - Author
Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Hematol, Zagreb, Croatia - Author
See more

Abstract

For over two decades, the EBMT has updated recommendations on indications for haematopoietic cell transplantation (HCT) practice based on clinical and scientific developments in the field. This is the eighth special EBMT report on the indications for HCT for haematological diseases, solid tumours and immune disorders. Our aim is to provide general guidance on HCT indications according to prevailing clinical practice in EBMT countries and centres. In order to inform patient decisions, these recommendations must be considered in conjunction with the risk of the disease, risk of HCT procedure and non-transplant strategies, including evolving cellular therapies. HCT techniques are constantly evolving and we make no specific recommendations, but encourage harmonisation of practice, where possible, to ensure experience across indications can be meaningfully aggregated via registry outputs. We also recommend working according to JACIE accreditation standards to maintain quality in clinical and laboratory components of practice, including benchmarking of survival outcomes. Since the last edition, the COVID-19 pandemic has affected clinical decision making and activity across indications. Although the full impact of the pandemic is yet to be determined, we recommend that decision making across indications is delivered with ongoing reference to EBMT and national COVID-19 guidance, in accordance with current local conditions.
[+]

Keywords

Acute lymphoblastic-leukemiaAcute myeloid-leukemiaBone-marrow-transplantationCord blood transplantationEuropeHematologic diseaseHematologic diseasesHematopoietic stem cell transplantationHigh-dose chemotherapyHumanHumansImmune system diseasesImmunopathologyLong-term outcomesLymphoma working partyMinimal residual diseaseNeoplasmNeoplasmsSevere aplastic-anemiaUnrelated donor transplantation

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Bone Marrow Transplantation due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 6/26, thus managing to position itself as a Q1 (Primer Cuartil), in the category Transplantation.

This publication has been distinguished as a “Highly Cited Paper” by the agencies WoS (ESI, Clarivate) and ESI (Clarivate), meaning that it ranks within the top 1% of the most cited articles in its thematic field during the year of its publication. In terms of the observed impact of the contribution, this work is considered one of the most influential worldwide, as it is recognized as highly cited. (source consulted: ESI Nov 13, 2025)

And this is evidenced by the extremely high normalized impacts through some of the main indicators of this type, which, although dynamic over time and dependent on the set of average global citations at the time of calculation, already indicate that they are well above the average in different agencies:

  • Normalization of citations relative to the expected citation rate (ESI) by the Clarivate agency: 24.87 (source consulted: ESI Nov 13, 2025)
  • Weighted Average of Normalized Impact by the Scopus agency: 26.42 (source consulted: FECYT Mar 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2026-04-05, the following number of citations:

  • WoS: 241
  • Scopus: 288
  • Europe PMC: 66
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-05:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 380.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 381 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 44.
  • The number of mentions on the social network X (formerly Twitter): 63 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
  • Assignment of a Handle/URN as an identifier within the deposit in the Institutional Repository: https://repositorio.uam.es/handle/10486/707493
[+]

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Croatia; France; Germany; Italy; Netherlands; Poland; United Kingdom.

[+]